Seoul, South Korea

Peter Verwilst

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Korea University Research and Business Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Verwilst. Retrieved from https://idiyas.com/inventor/peter-verwilst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peter Verwilst and a Fluorescent Probe for Amyloid Beta Plaques

Introduction

Peter Verwilst is an inventor associated with Seoul, South Korea, and the Korea University Research and Business Foundation. His work includes an invention aimed at improving the imaging of amyloid beta (Aβ) plaques, which are relevant to Alzheimer’s disease research.

Latest Patents

Verwilst is credited with 1 patent: “Two-photon fluorescent probe compound selective for amyloid beta plaques and method for imaging amyloid beta plaques using same.” The invention describes a coumarin or iminocoumarin-based two-photon fluorescent probe designed to combine efficient blood-brain barrier permeability with reduced background fluorescence. Its stated properties include a strong two-photon fluorescence cross-section and selectivity and sensitivity for Aβ plaques, supporting high signal-to-noise imaging. The probe may be useful in neurodegenerative disease research, including work on the early diagnosis and treatment of Alzheimer’s disease.

Career Highlights

The available information connects Verwilst’s patent work with the Korea University Research and Business Foundation. The invention focuses on a specialized imaging tool for studying Aβ plaques in the brain.

Collaborations

Jong Seung Kim and Jinwoo Shin are identified as Verwilst’s coworkers. Their names are associated with the collaborative research context provided for the patent.

Conclusion

Peter Verwilst’s listed patent presents a fluorescent imaging approach designed to help researchers detect amyloid beta plaques and advance Alzheimer’s disease research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…